Nebula Research & Development LLC Health Catalyst, Inc. Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
A detailed history of Nebula Research & Development LLC transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 36,038 shares of HCAT stock, worth $289,745. This represents 0.04% of its overall portfolio holdings.
Number of Shares
36,038
Previous 11,413
215.76%
Holding current value
$289,745
Previous $85.9 Million
167.96%
% of portfolio
0.04%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding HCAT
# of Institutions
167Shares Held
50.3MCall Options Held
2.51MPut Options Held
1.8K-
Black Rock Inc. New York, NY5.43MShares$43.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$36.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.96MShares$31.8 Million2.3% of portfolio
-
Impax Asset Management Group PLC2.55MShares$20.5 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.41MShares$19.4 Million0.01% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $440M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...